310
Views
39
CrossRef citations to date
0
Altmetric
Original Article

Self-report of illicit substance use versus urine toxicology results from at-risk pregnant women

, , &
Pages 372-380 | Published online: 27 Sep 2010

References

  • ACOG. (2004). ACOG committee opinion #294: At-risk drinking and illicit drug use: Ethical issues in obstetric and gynecologic practice. Obstetrics and Gynecology, 103, 1021–1031.
  • Babor, T. F., Steinberg, K., Anton, R. A. Y., & Del Boca, F. (2000). Talk is cheap: Measuring drinking outcomes in clinical trials (*). (Statistical data included). Journal of Studies on Alcohol, 61, 55.
  • Barnea, Z., Rahav, G., & Teichman, M. (1987). The reliability and consistency of self-reports on substance use in a longitudinal study. British Journal of Addiction, 82, 891–898.
  • Chang, G., Wilkins-Haug, L., Berman, S., & Goetz, M. (1999). The TWEAK: Application in a prenatal setting. Journal of Studies on Alcohol, 60, 306–309.
  • Chasnoff, I. J., Griffith, D. R., Freier, C., & Murray, J. (1992). Cocaine/polydrug use in pregnancy: Two-year follow-up. Pediatrics, 89, 284–289.
  • Chasnoff, I. J., McGourty, R. F., Bailey, G. W., Hutchins, E., Lightfoot, S. O., Pawson, L. L., Fahey, C., May, B., Brodie, P., McCulley, L., & Campbell, J. (2005). The 4P's Plus screen for substance use in pregnancy: Clinical application and outcomes. Journal of Perinatology, 25, 368–374.
  • Chasnoff, I. J., Wells, A. M., McGourty, R. F., & Bailey, L. K. (2007). Validation of the 4P's Plus screen for substance use in pregnancy validation of the 4P's Plus. Journal of Perinatology, 27, 744–748.
  • Christmas, J. T., Knisely, J. S., Dawson, K. S., Dinsmoor, M. J., Weber, S. E., & Schnoll, S. H. (1992). Comparison of questionnaire screening and urine toxicology for detection of pregnancy complicated by substance use. Obstetrics & Gynecology, 80, 750–754.
  • Cornelius, M. D., Goldschmidt, L., Day, N. L., & Larkby, C. (2002). Alcohol, tobacco and marijuana use among pregnant teenagers: 6-year follow-up of offspring growth effects. Neurotoxicology and Teratology, 24, 703–710.
  • Del Boca, F. K. & Noll, J. A. (2000). Truth or consequences: The validity of self-report data in health services research on addiction. Addiction, 95, 347–360.
  • Ebrahim, S. H. & Gfroerer, J. (2003). Pregnancy-related substance use in the United States during 1996–1998. Obstetrics and Gynecology, 101, 374–379.
  • Funkhouser, A. W., Butz, A. M., Feng, T. I., McCaul, M. E., & Rosenstein, B. J. (1993). Prenatal care and drug use in pregnant women. Drug and Alcohol Dependence, 33, 1–9.
  • Horrigan, T. J., Piazza, N. J., & Weinstein, L. (1996). The substance abuse subtle screening inventory is more cost effective and has better selectivity than urine toxicology for the detection of substance abuse in pregnancy. Journal of Perinatology, 16, 326–330.
  • Howell, E. M., Heiser, N., & Harrington, M. (1999). A review of recent findings on substance abuse treatment for pregnant women. Journal of Substance Abuse Treatment, 16, 195–219.
  • Jones, E. & Sigall, H. (1970). The bogus pipeline: A new paradigm for measuring affect and attitude. Psychological Bulletin, 76, 349–364.
  • Kaltenbach, K., Berghella, V., & Finnegan, L. (1998). Opioid dependence during pregnancy. Substance Abuse in Pregnancy, 25, 139–151.
  • Kaltenbach, K. & Finnegan, L. P. (1986). Neonatal abstinence syndrome, pharmacotherapy and developmental outcome. Neurobehavioral Toxicology and Teratology, 8, 353–355.
  • Kilpatrick, B., Howlett, M., Sedgwick, P., & Ghodse, A. H. (2000). Drug use, self report and urinalysis. Drug and Alcohol Dependence, 58, 111–116.
  • Kroenke, K. M. D., Spitzer, R. L. M. D., & Williams, J. B. W. D. S. W. (2003). The patient health questionnaire-2: Validity of a two-item depression screener. Medical Care, 41, 1284–1292.
  • Lowe, J. B., Windsor, R. A., Adams, B., Morris, J., & Reese, Y. (1986). Use of a bogus pipeline method to increase accuracy of self-reported alcohol consumption among pregnant women. Journal of Studies on Alcohol, 47, 173–175.
  • Magura, S. & Kang, S.-Y. (1996). Validity of self-reported drug use in high risk populations: A meta-analytical review. Substance Use & Misuse, 31, 1131–1153.
  • Marques, P. R., Tippetts, A. S., & Branch, D. G. (1993). Cocaine in the hair of mother-infant pairs: Quantitative analysis and correlations with urine measures and self-report. American Journal of Drug & Alcohol Abuse, 19, 159–175.
  • McLellan, A. T., Luborsky, L., Woody G. E., & O‘Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients: The addiction severity index. The Journal of Nervous and Mental Disease, 168, 26–33.
  • Ostrea, E. M., Ostrea, A. R., & Simpson, P. M. (1997). Mortality within the first 2 years in infants exposed to cocaine, opiate, or cannabinoid during gestation. Pediatrics, 100, 79–83.
  • Rockett, I. R. H., Putnam, S. L., Jia, H., & Smith, G. S. (2006). Declared and undeclared substance use among emergency department patients: A population-based study. Addiction, 101, 706–712.
  • Roese, N. & Jamieson, D. (1993). Twenty years of bogus pipeline research: A critical review and meta-analysis. Psychological Bulletin, 114, 363–375.
  • Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996). The inventory of depressive symptomatology (IDS) psychometric properties. Psychological Medicine, 26, 477–486.
  • Russell, M. (1996). Detecting risk drinking during pregnancy: A comparison of four screening questionnaires. American Journal of Public Health, 86, 1435–1439.
  • San, L., Torrens, M., Tato, J., Castillo, C., de la Torre, R., & Arranz, B. (1998). Monitoring patterns of substance use in drug-dependent patients. Journal of Substance Abuse Treatment, 15, 425–430.
  • Sheehan, D., Lecrubier, Y., Sheehan, K., Amorim, P., Janava, J., Weiller, E., Hergueta, T., Baker, R., & Dunbar, G. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59, 22–33.
  • Sherman, M. F., & Bigelow, G. E. (1992). Validity of patients' self-reported drug use as a function of treatment status. Drug & Alcohol Dependence, 30, 1–11.
  • Sobell, L., Brown, J., Leo, G., & Sobell, M. (1996). The reliability of the alcohol timeline follow back when administered by telephone and by computer. Drug and Alcohol Dependence, 42, 49–54.
  • Strandberg-Larsen, K., Andersen, A. M., Olsen, J., Nielsen, N. R., & Grnbaek, M. (2006). Do women give the same information on binge drinking during pregnancy when asked repeatedly? European Journal of Clinical Nutrition, 60, 1294–1298.
  • Zanis, D. A., McLellan, A. T., & Randall, M. (1994). Can you trust patient self-reports of drug use during treatment? Drug & Alcohol Dependence, 35, 127–132.
  • Zuckerman, B., Frank, D., Hingson, R., Amaro, H., Levenson, S., Kayne, H., Parker, S., Vinci, R., Aboagye, K., Fried, L., Cabral, H., Timperi, R., & Bauchner, H. (1989). Effects on maternal marijuana and cocaine use on fetal growth. The New England Journal of Medicine, 320, 762–768.
  • Zuckerman, B., Frank, D. A., & Mayes, L. (2002). Cocaine-exposed infants and developmental outcomes: “Crack kids” revisited. The journal of the American Medical Association, 287, 1990–1991.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.